ABT - Abbott Laboratories
Close
113.27
0.510 0.450%
Share volume: 4,320,043
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$112.76
0.51
0.45%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-01 | 2023-02-17 | 2023-05-04 | 2023-08-03 | 2023-11-01 | 2024-02-16 | 2024-05-02 | 2024-07-31 | |
| Assets | |||||||||
| Total Assets | 72.801 B | 74.438 B | 73.794 B | 73.354 B | 72.090 B | 73.214 B | 72.467 B | 73.017 B | |
| Current Assets | 24.845 B | 25.224 B | 24.377 B | 23.505 B | 22.664 B | 22.670 B | 22.376 B | 23.119 B | |
| Inventories | 5.734 B | 6.173 B | 6.673 B | 6.871 B | 6.650 B | 6.570 B | 6.827 B | 6.814 B | |
| Other Current Assets | 2.796 B | 2.663 B | 2.152 B | 2.307 B | 2.468 B | 2.256 B | 2.293 B | 2.232 B | |
| Short Term Investments | 2.796 B | 2.663 B | 2.152 B | 2.307 B | 2.468 B | 2.256 B | 2.293 B | 2.232 B | |
| Total Receivables | 6.408 B | 6.218 B | 6.020 B | 6.172 B | 6.499 B | 6.565 B | 6.605 B | 6.854 B | |
| Current Cash | 9.907 B | 10.170 B | 9.532 B | 8.155 B | 7.047 B | 7.279 B | 6.651 B | 7.219 B | |
| Total Non-current Assets | 47.956 B | 49.214 B | 49.417 B | 49.849 B | 49.426 B | 50.544 B | 50.091 B | 49.898 B | |
| Property Plant Equipment | 8.689 B | 9.162 B | 9.282 B | 9.449 B | 9.552 B | 10.154 B | 10.107 B | 10.233 B | |
| Other Assets | 5.369 B | 6.033 B | 6.426 B | 6.509 B | 6.527 B | 7.097 B | 7.487 B | 7.653 B | |
| Intangible Assets | 10.850 B | 10.454 B | 10.006 B | 9.834 B | 9.282 B | 8.815 B | 8.296 B | 7.827 B | |
| Goodwill | 22.284 B | 22.799 B | 22.927 B | 23.258 B | 23.277 B | 23.679 B | 23.383 B | 23.308 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 72.801 B | 74.438 B | 73.794 B | 73.354 B | 72.090 B | 73.214 B | 72.467 B | 73.017 B | |
| Total liabilities | 37.126 B | 37.752 B | 36.784 B | 36.180 B | 34.609 B | 34.611 B | 33.657 B | 33.699 B | |
| Total current liabilities | 13.365 B | 15.489 B | 14.530 B | 14.350 B | 13.042 B | 13.841 B | 14.021 B | 13.760 B | |
| Accounts Payable | 4.133 B | 4.607 B | 4.167 B | 4.211 B | 3.961 B | 4.295 B | 4.178 B | 4.125 B | |
| Other liabilities | 8.255 B | 5.588 B | 7.417 B | 7.038 B | 6.877 B | 5.430 B | 6.827 B | 6.558 B | |
| Current long term debt | 1.117 B | 2.251 B | 2.285 B | 2.284 B | 1.051 B | 1.080 B | 2.010 B | 1.615 B | |
| Long term debt | 15.297 B | 14.522 B | 14.615 B | 14.562 B | 14.477 B | 13.599 B | 12.576 B | 13.139 B | |
| Other liabilities | 8.255 B | 5.588 B | 7.417 B | 7.038 B | 6.877 B | 5.430 B | 6.827 B | 6.558 B | |
| Minority interest | 209.000 M | 219.000 M | 222.000 M | 230.000 M | 213.000 M | 224.000 M | 233.000 M | 242.000 M | |
| Total Shareholder equity | 35.675 B | 36.686 B | 37.010 B | 37.174 B | 37.481 B | 38.603 B | 38.810 B | 39.318 B | |
| Common stock | 1.753 B | 1.743 B | 1.742 B | 1.740 B | 1.739 B | 1.739 B | 1.740 B | 1.743 B | |
| Retained earnings | 35.115 B | 35.257 B | 35.868 B | 36.355 B | 36.920 B | 37.554 B | 38.011 B | 38.354 B |